A consortium, consisting of Priveq Investment, Investor Growth Capital, Industrifonden, Start Invest and employees, has sold 95% of the shareholding in Swedish pharmaceutical company Carmel Pharma AB.
This article is only available to subscribers to unquote.com. Subscribers just need to log in below for immediate access. Not a subscriber? Sign up now for immediate free trial access
Sign up
Free trial
Try unquote.com free for 2 weeks. A trial will give you access to the entire site.